Market view
Stock chart
Coverage
Analyses on Medipress Healt (3)
- March 18, 2026March 18, 2026
- Follow-up
Medipress Follow-up: P-Cure Is Advancing, So Why Is the Dollar Valuation Flat?
P-Cure showed real operating and commercial progress in 2025, but Medipress still carries the holding at the same dollar value because that progress was not accompanied by a new priced round or another outside event that set a higher price.
- Follow-up
Medipress Follow-up: Why the Cash Cushion Still Does Not Equal Cash for Unit Holders
Medipress's cash cushion is real, but it is still trapped inside a partnership wrapper where Run Off is only an in-principle decision, control remains with the general partner, and time itself erodes the value that may eventually reach unit holders.
Medipress Health 2025: Cash Still Exceeds the Market Value, but Access to It Is Not Clean Yet
Medipress is trading at a deep discount to both cash and book equity because the market sees a Run Off vehicle with one dominant asset and value that is still not sufficiently accessible to unit holders.
Same sector
